Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Carnitech LLC operates in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 2 pending office actions. These actions are distributed across 2 distinct examiners and 1 distinct art unit. This structure shows that the company interacts with multiple different examiners within a single specialized section of the patent office.
The busiest examiner for the company is KELLY-O'NEILL, YOLANDA LYNNETTE. This examiner is handling 1 busiest examiner pending office action. This specific action is part of the total pending office actions for the company. KELLY-O'NEILL, YOLANDA LYNNETTE is one of the individuals responsible for the current workload in the Biotechnology & Pharmaceuticals sector.
The presence of multiple examiners within the 1 distinct art unit suggests a concentrated examination environment. While the 2 pending office actions are split, they remain within the same art unit. This concentration allows for a consistent technological focus during prosecution, even as the company engages with different examiners. Practitioners can expect the distinct examiners to operate under the same art unit guidelines.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 33.3% | +29.9% |
| STOCKTON, LAURA LYNNE | 1 | 75.2% | +33.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18393246 | PROCESS FOR PRODUCING L-CARNITINE | KELLY-O'NEILL, YOLANDA LYNNETTE | — |
| 18368754 | PROCESS FOR PRODUCING BRIVARACETAM AND INTERMEDIATES THEREOF | STOCKTON, LAURA LYNNE | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18393246 | PROCESS FOR PRODUCING L-CARNITINE | KELLY-O'NEILL, YOLANDA LYNNETTE | — | §102§103DP | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18368754 | PROCESS FOR PRODUCING BRIVARACETAM AND INTERMEDIATES THEREOF | STOCKTON, LAURA LYNNE | 1626 | §102 | Non-Final OA | — | Pending | Sep 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial